BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7195729)

  • 21. [Transmission electron microscopy of in vitro cultivated squamous cell carcinoma cell lines].
    Wustrow TP; Schinko I; Zenner HP
    Laryngol Rhinol Otol (Stuttg); 1988 Sep; 67(9):469-74. PubMed ID: 3172945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spectral karyotyping analysis of head and neck squamous cell carcinoma.
    Singh B; Gogineni S; Goberdhan A; Sacks P; Shaha A; Shah J; Rao P
    Laryngoscope; 2001 Sep; 111(9):1545-50. PubMed ID: 11568603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dysregulation of the repressive H3K27 trimethylation mark in head and neck squamous cell carcinoma contributes to dysregulated squamous differentiation.
    Gannon OM; Merida de Long L; Endo-Munoz L; Hazar-Rethinam M; Saunders NA
    Clin Cancer Res; 2013 Jan; 19(2):428-41. PubMed ID: 23186778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preservation of morphological, functional, and karyotypic traits during long-term culture and in vivo passage of two human skin squamous cell carcinomas.
    Tilgen W; Boukamp P; Breitkreutz D; Dzarlieva RT; Engstner M; Haag D; Fusenig NE
    Cancer Res; 1983 Dec; 43(12 Pt 1):5995-6011. PubMed ID: 6196111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of four new cell lines derived from human squamous carcinomas of the uterine cervix.
    Kelland LR; Burgess L; Steel GG
    Cancer Res; 1987 Sep; 47(18):4947-52. PubMed ID: 2441858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo.
    Duffey DC; Chen Z; Dong G; Ondrey FG; Wolf JS; Brown K; Siebenlist U; Van Waes C
    Cancer Res; 1999 Jul; 59(14):3468-74. PubMed ID: 10416612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA--cytometric studies on xenografts of squamous cell carcinomas of the head and neck.
    Elprana D; Kuijpers W; Peperkamp AR; Wagener DJ
    Anticancer Res; 1991; 11(5):1943-9. PubMed ID: 1768066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of two newly established cell lines derived from squamous cell carcinomas of the oesophagus.
    Sarbia M; Bösing N; Hildebrandt B; Koldovsky P; Gerharz CD; Gabbert HE
    Anticancer Res; 1997; 17(3C):2185-92. PubMed ID: 9216685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment and characterization of two new squamous cell carcinoma cell lines derived from tumors of the head and neck.
    Sacks PG; Parnes SM; Gallick GE; Mansouri Z; Lichtner R; Satya-Prakash KL; Pathak S; Parsons DF
    Cancer Res; 1988 May; 48(10):2858-66. PubMed ID: 2452013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abrogation of VEGF expression in human head and neck squamous cell carcinoma decreases angiogenic activity in vitro and in vivo.
    Riedel F; Götte K; Li M; Hörmann K; Grandis JR
    Int J Oncol; 2003 Sep; 23(3):577-83. PubMed ID: 12888890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T-lymphocyte maturation-associated protein gene as a candidate metastasis suppressor for head and neck squamous cell carcinomas.
    Beder LB; Gunduz M; Hotomi M; Fujihara K; Shimada J; Tamura S; Gunduz E; Fukushima K; Yaykasli K; Grenman R; Shimizu K; Yamanaka N
    Cancer Sci; 2009 May; 100(5):873-80. PubMed ID: 19445022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytogenetic evidence of the multistep origin of head and neck squamous cell carcinomas.
    Cowan JM; Beckett MA; Ahmed-Swan S; Weichselbaum RR
    J Natl Cancer Inst; 1992 May; 84(10):793-7. PubMed ID: 1573667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative study of the sensitivity of head and neck cell lines to methotrexate (MTX) and the analog 10-ethyl, 10-deazaaminopterin (10-EdAM).
    Brown DH; Braakhuis BJ; Van Dongen GA; Snow GB
    Otolaryngol Head Neck Surg; 1990 Jan; 102(1):20-5. PubMed ID: 2106113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between head and neck squamous cell carcinomas and fibrinolytic factors. Immunohistological study.
    Itaya T; Suzuki K; Takagi I; Motai H; Baba S
    Acta Otolaryngol Suppl; 1996; 525():113-9. PubMed ID: 8908283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Annulate lamellae of in vitro cultivated squamous epithelial cancer cell lines].
    Wustrow TP; Schinko I
    Laryngol Rhinol Otol (Stuttg); 1988 Aug; 67(8):416-9. PubMed ID: 3210876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biologic properties of three newly established human esophageal carcinoma cell lines.
    Hu CP; Hsieh HG; Chien KY; Wang PY; Wang CI; Chen CY; Lo SJ; Wuu KD; Chang CM
    J Natl Cancer Inst; 1984 Mar; 72(3):577-83. PubMed ID: 6583441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. STAT 3 activation in head and neck squamous cell carcinomas is controlled by the EGFR.
    Hambek M; Baghi M; Strebhardt K; May A; Adunka O; Gstöttner W; Knecht R
    Anticancer Res; 2004; 24(6):3881-6. PubMed ID: 15736426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrastructural analysis of colonies growing in a human tumor cloning system.
    Harris GJ; Zeagler J; Hodach A; Casper J; Harb J; Von Hoff DD
    Cancer; 1982 Aug; 50(4):722-6. PubMed ID: 7093906
    [No Abstract]   [Full Text] [Related]  

  • 39. Low incidence of ras oncogene activation in human squamous cell carcinomas.
    Rumsby G; Carter RL; Gusterson BA
    Br J Cancer; 1990 Mar; 61(3):365-8. PubMed ID: 2183872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro proliferation of primary human head and neck squamous cell carcinomas evaluated by flow cytometry.
    Bijman JT; Wagener DJ; Wessels JM; Elprana D; van den Broek P
    Cancer Lett; 1987 Jul; 36(1):71-81. PubMed ID: 3581058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.